WINNIPEG, MANITOBA--(Marketwire - March 27, 2008) - Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company dedicated to the discovery and development of diagnostic tools and therapeutic products for cancer, today announces a non-brokered private placement offering (the “Offering”) of up to 5,000,000 units (“Units”) at a price of $0.15 per Unit for gross proceeds of up to $750,000. Each Unit will be comprised of one common share of the Company (a “Share”) and one half of one Share purchase warrant (a “Warrant”). Each whole Warrant will entitle the holder to purchase one Share at a price of $0.25 for a period of 12 months from the date the Warrant is issued.
